BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3013828)

  • 1. Transposable resistance to trimethoprim and 0/129 in Vibrio cholerae.
    Goldstein F; Gerbaud G; Courvalin P
    J Antimicrob Chemother; 1986 May; 17(5):559-69. PubMed ID: 3013828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of trimethoprim and O/129 resistance in Vibrio cholerae.
    Gerbaud G; Dodin A; Goldstein F; Courvalin P
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):265-73. PubMed ID: 3008635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid trimethoprim resistance in Vibrio cholerae: migration of the type I dihydrofolate reductase gene out of the Enterobacteriaceae.
    Young HK; Amyes SG
    J Antimicrob Chemother; 1986 Jun; 17(6):697-703. PubMed ID: 3733590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139.
    Yamamoto T; Nair GB; Takeda Y
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):131-6. PubMed ID: 7640673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic, biochemical and molecular characterization of strains of Vibrio cholerae multiresistant to antibiotics.
    Ouellette M; Gerbaud G; Courvalin P
    Ann Inst Pasteur Microbiol; 1988; 139(1):105-13. PubMed ID: 3260105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
    Waldor MK; Tschäpe H; Mekalanos JJ
    J Bacteriol; 1996 Jul; 178(14):4157-65. PubMed ID: 8763944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferable plasmid-mediated drug resistance among non-O1 Vibrio cholerae and rough strains of Vibrio cholerae from Tamilnadu, India.
    Sundaram S; Murthy KV
    J Hyg (Lond); 1984 Feb; 92(1):59-65. PubMed ID: 6607275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of resistance to trimethoprim in enterobacteria isolated in a Parisian hospital.
    Papadopoulou B; Gerbaud G; Courvalin P; Acar JF; Goldstein FW
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(3):239-51. PubMed ID: 3322170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
    Dupont MJ; Jouvenot M; Couetdic G; Michel-Briand Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):280-1. PubMed ID: 3885851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-resistance and transferable R plasmids in Vibrio cholerae O-1 and non O-1, V. fluvialis and V. parahaemolyticus recently isolated from human sources].
    Matsushita S; Yamada S; Kudoh Y; Ohashi M
    Kansenshogaku Zasshi; 1987 Feb; 61(2):109-17. PubMed ID: 3112272
    [No Abstract]   [Full Text] [Related]  

  • 11. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
    Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
    J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to trimethoprim and 2,4-diamino-6,7-diisopropyl-pteridine (0/129) in Pasteurella haemolytica.
    Escande F; Gerbaud G; Martel JL; Courvalin P
    Vet Microbiol; 1991 Jan; 26(1-2):107-14. PubMed ID: 2024433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a new drug-resistance plasmid from a strain of Vibrio parahaemolyticus.
    Arai T; Hamashima H; Hasegawa H
    Microbiol Immunol; 1985; 29(2):103-12. PubMed ID: 4010538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferable resistance to the vibriostatic agent 2,4-diamino-6,7-diisopropyl-pteridine (O/129) in Vibrio cholerae.
    Matsushita S; Kudoh Y; Ohashi M
    Microbiol Immunol; 1984; 28(10):1159-62. PubMed ID: 6394970
    [No Abstract]   [Full Text] [Related]  

  • 15. Transferable plasmid-mediated antibiotic resistance in Acinetobacter.
    Goldstein FW; Labigne-Roussel A; Gerbaud G; Carlier C; Collatz E; Courvalin P
    Plasmid; 1983 Sep; 10(2):138-47. PubMed ID: 6356187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland].
    Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z
    Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the type I and type II DHFR genes in trimethoprim-resistant urinary isolates of Escherichia coli from Greece.
    Tsakris A; Johnson AP; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1993 May; 31(5):665-71. PubMed ID: 8392996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of trimethoprim resistance by use of probes specific for transposon Tn7.
    Pulkkinen L; Huovinen P; Vuorio E; Toivanen P
    Antimicrob Agents Chemother; 1984 Jul; 26(1):82-6. PubMed ID: 6089656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inc J plasmids identified for the first time in Vibrio cholerae El Tor].
    Korichi MN; Belhocine S; Rahal K
    Med Trop (Mars); 1997; 57(3):249-52. PubMed ID: 9513150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014.
    Eibach D; Herrera-León S; Gil H; Hogan B; Ehlkes L; Adjabeng M; Kreuels B; Nagel M; Opare D; Fobil JN; May J
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004751. PubMed ID: 27232338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.